We found that MS-275 treatment of differentiated C2C12 myotubes improved PA-induced insulin resistance and decreased stress signals and inflammatory cytokine expression via the inhibition of JNK and NK-κB. The gene discussed is MAPK8; the disease is Insulin resistance.